ESALF - Eisai sees a sharp rise in patients on Biogen-partnered Alzheimer's drug
2023-11-07 06:59:00 ET
More on Biogen, Eisai, etc.
- Stocks To Watch: Tesla, Netflix, And AT&T Headline Big Week Of Earnings
- Biogen - Revised Revenue Forecasting To 2030 - New CEO Faces Major Challenges
- Biogen Inc. (BIIB) Management presents at Decentralized Clinical Trials in Focus Conference (Transcript)
- Earnings week ahead: Disney, AMC, Plug Power, Lucid, Realty Income and more
- Biogen says new Leqembi formulation better than IV version
For further details see:
Eisai sees a sharp rise in patients on Biogen-partnered Alzheimer’s drug